Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.72 |
| ▸ | CASP2 | P42575 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18248661 | 0.89 | FAAH (0.84) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL14946400 | 0.89 | FAAH (0.84) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL21090463 | 0.85 | FAAH (0.84) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL26497453 | 0.85 | CASP2 (0.80) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL3915907 | 0.85 | FAAH (1.00) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL11104897 | 0.85 | FAAH (1.00) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL2343012 | 0.85 | FAAH (1.00) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL8205915 | 0.85 | FAAH (1.00) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL4147161 | 0.85 | FAAH (1.00) | FAAHCASP2EPHX2NAAADNM1 | |
| SCHEMBL4146733 | 0.85 | FAAH (1.00) | FAAHCASP2EPHX2NAAADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180141965-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS (GR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141965-A1 | AUTOTAXIN INHIBITORS AND USES THEREOF | ENPP2, SPINT2, SERPINB1 | FAAH 1500/4885CASP2 2019/4885EPHX2 3214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.